Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Forum for Health Economics & Policy

Editor-in-Chief: Goldman, Dana / Romley, John


CiteScore 2018: 0.89

SCImago Journal Rank (SJR) 2018: 0.314
Source Normalized Impact per Paper (SNIP) 2018: 0.548

Online
ISSN
1558-9544
See all formats and pricing
More options …

The Business Case for Diabetes Disease Management for Managed Care Organizations

Nancy Beaulieu / David M Cutler / Katherine Ho / George Isham / Tammie Lindquist / Andrew Nelson / Patrick O'Connor
Published Online: 2006-12-01 | DOI: https://doi.org/10.2202/1558-9544.1072

Diabetes is a common and very costly chronic disease. There is broad-based agreement on how to manage diabetes, yet less than 40% of adults with diabetes achieve guideline-recommended levels of medical care. We investigate the reasons for this phenomenon by examining the business case for improved diabetes care from the perspective of a single health plan (HealthPartners of Minnesota). The potential benefits accruing to a health plan from diabetes disease management include medical care cost savings and higher premiums. The potential costs to the health plan derive from disease management program costs and adverse selection. We find that the implementation of diabetes disease management coincided with large health improvements. For a defined population of diabetes patients, medical care cost savings over several years were small in the closed panel medical group but moderate for the health plan overall. We find evidence that adverse selection and the timing of cost and benefits worsen the health plan business case. In addition, the payment systems, from purchaser to health plan and health plan to provider, are very weakly connected to the quality of diabetes care, further weakening the business case. Finally, overlapping provider networks create a public goods externality that limits the health plan’s ability to privately capture the benefits from its investments. Nonetheless, it is clear that improved diabetes care affords economic benefits to health plans as well as valuable quality of life benefits to adults with diabetes.

Keywords: diabetes; disease management; HMO

About the article

Published Online: 2006-12-01


Citation Information: Forum for Health Economics & Policy, Volume 9, Issue 1, ISSN (Online) 1558-9544, DOI: https://doi.org/10.2202/1558-9544.1072.

Export Citation

©2011 Walter de Gruyter GmbH & Co. KG, Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Gang Luo, Bryan L Stone, Corinna Koebnick, Shan He, David H Au, Xiaoming Sheng, Maureen A Murtaugh, Katherine A Sward, Michael Schatz, Robert S Zeiger, Giana H Davidson, and Flory L Nkoy
JMIR Research Protocols, 2019, Volume 8, Number 6, Page e13783
[2]
Cristina Ugolini, Matteo Lippi Bruni, Anna Caterina Leucci, Gianluca Fiorentini, Elena Berti, Lucia Nobilio, and Maria Luisa Moro
SSRN Electronic Journal , 2019
[4]
Wynand P.M.M. van de Ven and Frederik T. Schut
Health Affairs, 2008, Volume 27, Number 3, Page 771
[5]
David M. Cutler
De Economist, 2006, Volume 154, Number 1, Page 1
[6]
Melinda Beeuwkes Buntin, Arvind K. Jain, Soeren Mattke, and Nicole Lurie
Journal of General Internal Medicine, 2009, Volume 24, Number 5, Page 649
[7]
Patrick J. O’Connor, JoAnn M. Sperl-Hillen, and Thomas E. Kottke
Current Cardiovascular Risk Reports, 2009, Volume 3, Number 1, Page 71
[8]
Timothy Simcoe, Maryaline Catillon, and Paul Gertler
Health Economics, 2018
[9]
Wynand P. M. M. van de Ven, Richard C. van Kleef, and Rene C. J. A. van Vliet
Health Affairs, 2015, Volume 34, Number 10, Page 1713
[10]
David M. Cutler
Innovation Policy and the Economy, 2011, Volume 11, Page 1
[11]
Gang Luo and Katherine Sward
JMIR Medical Informatics, 2017, Volume 5, Number 3, Page e32
[12]
Gang Luo, Bryan L Stone, Michael D Johnson, Peter Tarczy-Hornoch, Adam B Wilcox, Sean D Mooney, Xiaoming Sheng, Peter J Haug, and Flory L Nkoy
JMIR Research Protocols, 2017, Volume 6, Number 8, Page e175
[13]
Gang Luo
Health Information Science and Systems, 2016, Volume 4, Number 1
[14]
David Anderson and Margrét Bjarnadóttir
IIE Transactions on Healthcare Systems Engineering, 2016, Volume 6, Number 1, Page 22
[15]
Gang Luo, Bryan L Stone, Farrant Sakaguchi, Xiaoming Sheng, and Maureen A Murtaugh
JMIR Research Protocols, 2015, Volume 4, Number 4, Page e128
[16]
Martin Cherniack and Supriya Lahiri
Journal of Occupational and Environmental Medicine, 2010, Volume 52, Number 9, Page 934
[17]
Sharrel L. Pinto, Jinender Kumar, Gautam Partha, and Robert A. Bechtol
Population Health Management, 2014, Volume 17, Number 1, Page 21
[18]
Richard C van Kleef, Wynand PMM van de Ven, and René CJA van Vliet
Expert Review of Pharmacoeconomics & Outcomes Research, 2013, Volume 13, Number 6, Page 743
[19]
TERYL K. NUCKOLS, JOSÉ J. ESCARCE, and STEVEN M. ASCH
Milbank Quarterly, 2013, Volume 91, Number 2, Page 316
[20]
Wynand P.M.M. van de Ven, Konstantin Beck, Florian Buchner, Erik Schokkaert, F.T. (Erik) Schut, Amir Shmueli, and Juergen Wasem
Health Policy, 2013, Volume 109, Number 3, Page 226
[21]
Julien Mousquès, Yann Bourgueil, Philippe Le Fur, and Engin Yilmaz
Health Policy, 2010, Volume 98, Number 2-3, Page 131
[22]
Wynand P. M. M. Van de Ven
Health Economics, Policy and Law, 2011, Volume 6, Number 01, Page 147

Comments (0)

Please log in or register to comment.
Log in